FHS Adjunct Professor Dr. Samantha Pollard and Assistant Professor of Professional Practice Dr. Helen McTaggart-Cowan will be working with cancer patients and caregivers to carry out investigations about precision oncology clinical trials frameworks, and collect perspectives from patients with advanced ovarian cancer on HRD (homologous recombination deficiency) testing. Photo: Freepik

Cancer patients and caregivers to help develop new approaches for cancer clinical trials, testing

December 17, 2024
Print

BURNABY, BC – The Terry Fox Research Institute (TFRI) is funding a new national research initiative that will allow cancer patients and their caregivers to direct research in precision oncology over the next year.

The Patient Voices in Research initiative – which is designed, led, and adjudicated by cancer patients and survivors – is funding 10 team research projects from across Canada, including two in British Columbia. Investigative teams are receiving a total of $1.8M from the TFRI’s Marathon of Hope Cancer Centre’s Network (the Network) to conduct their research.

Dr. Samantha Pollard

One of projects based in BC is The Patient-driven Cancer Trials (PACT) project – a pan-Canadian study that is being led by Dr. Samantha Pollard, an adjunct professor at Simon Fraser University’s Faculty of Health Sciences (SFU FHS). Pollard’s team received $239,000 to create a more accessible and inclusive clinical trial framework for precision oncology that integrate patient and caregiver perspectives, needs, and values.

Precision oncology uses a patient’s genomic (genetic) information to apply tailored cancer prevention and treatment approaches, with the goal of improving patient quality and length of life. Pollard notes that one of the biggest challenges in this field is that “[p]recision medicine can only advance meaningfully if the outcomes generated are beneficial to patients.” She points out that current models of clinical trials can be costly for patients in terms of their time and energy, and early-stage trials might not generate outcomes that patients and their families consider meaningful.

“Through the PACT project, alongside patient partners, we will identify and prioritize features of clinical trial designs that align with patient expectations and motivations for participation. This work will help ensure that the design and conduct of clinical trials for precision oncology directly respond to the needs and preferences of those asked to participate.”

Throughout the PACT project, Dr. Pollard will be collaborating with the Network’s Patient Working Group, a national advisory group made up of over 30 cancer patients, survivors and caregivers. By engaging the Working Group in the selection and final reporting of the precision oncology research projects, TFRI is embedding patient leadership and participation into the Patient Voices in Research initiative from start to finish.

“People who have lived a cancer diagnosis or have accompanied a close family on their cancer journey know better than anyone what cancer care looks like today and what needs to improve,” says Darrell Fox, younger brother of Terry Fox and senior advisor at TFRI. “Like Terry, these cancer patients and survivors are driven by their own experiences to improve outcomes for future patients.”

Rosilene Kraft, a breast cancer patient in Coquitlam, BC remarked that the Patient Voices in Research initiative is truly unique in Canada. “I have participated in other initiatives like this, but this project is the first I’ve seen where the patients set the themes of the competition based on their priorities and then were the sole members of a panel reviewing and rating the research proposals presented. [T]he competition attracted applications of exceptional quality. I feel very proud of having been part of such an empowering initiative for patients.”

Dr. Helen McTaggart-Cowan

A second BC-based project that was also funded by the Patient Voices in Research initiative is being led by Dr. Helen McTaggart-Cowan, a scientist at BC Cancer and assistant professor of professional practice at

SFU’s Faculty of Health Sciences. She will be exploring the perspectives of patients, families and healthcare providers on the use of homologous recombination deficiency (HRD) testing – which can be used to tailor treatment to a patient’s genetic profile – to enhance health outcomes and quality of life in patients with advanced ovarian cancer. Details of her project can be found at the BC Cancer web site.

 

-  30   -

MEDIA CONTACTS

SHARON MAH, manager, Communications and Marketing
SFU Faculty of Health Sciences
fhscomm@sfu.ca   |   778-782-9947

SAMANTHA POLLARD, principal investigator, The PACT Project
SFU Faculty of Health Sciences
spollard@sfu.ca